Shineway Pharmaceutical Co.,Ltd   Report issue

For profit Phase 3 Phase 4
Founded: Hong Kong China (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2011
NCT01978730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Shineway Pharmaceutical Co.,Ltd